Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification

Ryan C Lynch¹, Dita Gratzinger², Ranjana H Advani^{3

4}

Affiliations

¹ Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
² Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
³ Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. radvani@stanford.edu.
⁴ Stanford University Medical Center, 875 Blake Wilbur Drive, Suite CC-2338, Stanford, CA, 94305-5821, USA. radvani@stanford.edu.

Published Erratum

Ryan C Lynch et al. Curr Treat Options Oncol. 2017 Oct.

. 2017 Oct;18(10):60.

doi: 10.1007/s11864-017-0499-4.

Ryan C Lynch¹, Dita Gratzinger², Ranjana H Advani^{3

4}

¹ Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
² Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
³ Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. radvani@stanford.edu.
⁴ Stanford University Medical Center, 875 Blake Wilbur Drive, Suite CC-2338, Stanford, CA, 94305-5821, USA. radvani@stanford.edu.

No abstract available

Erratum for

Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
Lynch RC, Gratzinger D, Advani RH. Lynch RC, et al. Curr Treat Options Oncol. 2017 Jul;18(7):45. doi: 10.1007/s11864-017-0483-z. Curr Treat Options Oncol. 2017. PMID: 28670664 Review.